{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:43:12Z","timestamp":1792856592888,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"European Joint Programme Rare Diseases","award":["G0H7520N"],"award-info":[{"award-number":["G0H7520N"]}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1226224N"],"award-info":[{"award-number":["1226224N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1S19723N"],"award-info":[{"award-number":["1S19723N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["K110523N"],"award-info":[{"award-number":["K110523N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["K143424N"],"award-info":[{"award-number":["K143424N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006325","name":"ARVO Foundation for Eye Research","doi-asserted-by":"publisher","award":["K128824N"],"award-info":[{"award-number":["K128824N"]}],"id":[{"id":"10.13039\/100006325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006325","name":"ARVO Foundation for Eye Research","doi-asserted-by":"publisher","award":["K118625N"],"award-info":[{"award-number":["K118625N"]}],"id":[{"id":"10.13039\/100006325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s13346-025-02036-y","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T17:27:05Z","timestamp":1769621225000},"page":"2921-2936","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Overcoming size barriers in retinal gene therapy via lipid nanoparticle-mediated delivery of full-length eys DNA"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5376-1554","authenticated-orcid":false,"given":"Sarah","family":"Goddaer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"De Coster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Callens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Van Caenegem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Van den Heule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob W. J.","family":"Collin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Peynshaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Van Nieuwerburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Braeckmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2244-1339","authenticated-orcid":false,"given":"Katrien","family":"Remaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"issue":"21","key":"2036_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113467","volume":"23","author":"T Ben-Yosef","year":"2022","unstructured":"Ben-Yosef T. Inherited retinal diseases. Int J Mol Sci. 2022;23(21):13467. https:\/\/doi.org\/10.3390\/ijms232113467.","journal-title":"Int J Mol Sci"},{"key":"2036_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.101029","volume":"89","author":"N Schneider","year":"2022","unstructured":"Schneider N, et al. Inherited retinal diseases: linking genes, disease-causing variants, and relevant therapeutic modalities. Prog Retin Eye Res. 2022;89:101029. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.101029.","journal-title":"Prog Retin Eye Res"},{"issue":"18","key":"2036_CR3","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/s0140-6736(06)69740-7","volume":"368","author":"DT Hartong","year":"2006","unstructured":"Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368(18):1795\u2013809. https:\/\/doi.org\/10.1016\/s0140-6736(06)69740-7.","journal-title":"Lancet"},{"issue":"3","key":"2036_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0039-6257(88)90085-9","volume":"33","author":"RA Pagon","year":"1988","unstructured":"Pagon RA. Retinitis pigmentosa. Surv Ophthalmol. 1988;33(3):137\u201377. https:\/\/doi.org\/10.1016\/0039-6257(88)90085-9.","journal-title":"Surv Ophthalmol"},{"key":"2036_CR5","first-page":"761","volume-title":"Retina (Fifth Edition)","author":"K Gregory-Evans","year":"2013","unstructured":"Gregory-Evans K, Pennesi ME, Weleber RG, et al. Chapter 40 - Retinitis Pigmentosa and Allied Disorders. In: Ryan SJ, et al., editors. Retina (Fifth Edition). London: W.B. Saunders; 2013. p. 761\u2013835."},{"issue":"3","key":"2036_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cells12030440","volume":"12","author":"S Hansen","year":"2023","unstructured":"Hansen S, McClements ME, Corydon TJ, Maclaren RE. Future perspectives of prime editing for the treatment of inherited retinal diseases. Cells. 2023;12(3):440. https:\/\/doi.org\/10.3390\/cells12030440.","journal-title":"Cells"},{"issue":"11","key":"2036_CR7","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/ng.241","volume":"40","author":"MM Abd El-Aziz","year":"2008","unstructured":"Abd El-Aziz MM, et al. EYS, encoding an ortholog of Drosophila spacemaker, is mutated in autosomal recessive retinitis pigmentosa. Nat Genet. 2008;40(11):1285\u20137. https:\/\/doi.org\/10.1038\/ng.241.","journal-title":"Nat Genet"},{"issue":"5","key":"2036_CR8","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ajhg.2008.10.014","volume":"83","author":"RW Collin","year":"2008","unstructured":"Collin RW, et al. Identification of a 2 Mb human ortholog of Drosophila eyes shut\/spacemaker that is mutated in patients with retinitis pigmentosa. Am J Hum Genet. 2008;83(5):594\u2013603. https:\/\/doi.org\/10.1016\/j.ajhg.2008.10.014.","journal-title":"Am J Hum Genet"},{"issue":"11","key":"2036_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166397","volume":"11","author":"G Alfano","year":"2016","unstructured":"Alfano G, et al. EYS is a protein associated with the ciliary axoneme in rods and cones. PLoS One. 2016;11(11):e0166397. https:\/\/doi.org\/10.1371\/journal.pone.0166397.","journal-title":"PLoS One"},{"key":"2036_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01843-z","author":"AB Garcia-Delgado","year":"2021","unstructured":"Garcia-Delgado AB, Valdes-Sanchez L, Morillo-Sanchez MJ, Ponte-Zu\u00f1iga B, Diaz-Corrales FJ, De La Cerda B. Dissecting the role of EYS in retinal degeneration: clinical and molecular aspects and its implications for future therapy. Orphanet J Rare Dis. 2021. https:\/\/doi.org\/10.1186\/s13023-021-01843-z.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"2036_CR11","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3390\/diagnostics13050850","volume":"13","author":"G Placidi","year":"2023","unstructured":"Placidi G, et al. Retinitis pigmentosa associated with EYS gene mutations: disease severity staging and central retina atrophy. Diagnostics. 2023;13(5):850. https:\/\/doi.org\/10.3390\/diagnostics13050850.","journal-title":"Diagnostics"},{"key":"2036_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-26017-0","volume":"12","author":"R Suvannaboon","year":"2022","unstructured":"Suvannaboon R, Pawestri AR, Jinda W, Tuekprakhon A, Trinavarat A, Atchaneeyasakul LO. Genotypic and phenotypic profiles of EYS gene-related retinitis pigmentosa: a retrospective study. Sci Rep. 2022;12:21494. https:\/\/doi.org\/10.1038\/s41598-022-26017-0.","journal-title":"Sci Rep"},{"key":"2036_CR13","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.omtn.2023.05.020","volume":"32","author":"RTW Schellens","year":"2023","unstructured":"Schellens RTW, et al. A protein domain-oriented approach to expand the opportunities of therapeutic exon skipping for USH2A-associated retinitis pigmentosa. Mol Ther Nucleic Acids. 2023;32:980\u201394. https:\/\/doi.org\/10.1016\/j.omtn.2023.05.020.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"2036_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","volume":"25","author":"ML Maeder","year":"2019","unstructured":"Maeder ML, et al. Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10. Nat Med. 2019;25(2):229\u201333. https:\/\/doi.org\/10.1038\/s41591-018-0327-9.","journal-title":"Nat Med"},{"issue":"2","key":"2036_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/emmm.201302948","volume":"6","author":"I Trapani","year":"2014","unstructured":"Trapani I, et al. Effective delivery of large genes to the retina by dual AAV vectors. EMBO Mol Med. 2014;6(2):194\u2013211. https:\/\/doi.org\/10.1002\/emmm.201302948.","journal-title":"EMBO Mol Med"},{"key":"2036_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adt9354","author":"R Ferla","year":"2025","unstructured":"Ferla R, et al. Retinal gene therapy for Stargardt disease with dual AAV intein vectors is both safe and effective in large animal models. Sci Adv. 2025. https:\/\/doi.org\/10.1126\/sciadv.adt9354.","journal-title":"Sci Adv"},{"issue":"4","key":"2036_CR17","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1039\/c7sc00097a","volume":"8","author":"JA Kretzmann","year":"2017","unstructured":"Kretzmann JA, et al. Synthetically controlling dendrimer flexibility improves delivery of large plasmid DNA. Chem Sci. 2017;8(4):2923\u201330. https:\/\/doi.org\/10.1039\/c7sc00097a.","journal-title":"Chem Sci"},{"issue":"2","key":"2036_CR18","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1021\/acsami.3c14714","volume":"16","author":"M Maeki","year":"2024","unstructured":"Maeki M, et al. Development of polymer-lipid hybrid nanoparticles for large-sized plasmid DNA transfection. ACS Appl Mater Interfaces. 2024;16(2):2110\u20139. https:\/\/doi.org\/10.1021\/acsami.3c14714.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"2036_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1089\/nat.2018.0721","volume":"28","author":"JA Kulkarni","year":"2018","unstructured":"Kulkarni JA, Cullis PR, Van Der Meel R. Lipid nanoparticles enabling gene therapies: from concepts to clinical utility. Nucleic Acid Ther. 2018;28(3):146\u201357. https:\/\/doi.org\/10.1089\/nat.2018.0721.","journal-title":"Nucleic Acid Ther"},{"issue":"8","key":"2036_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202001812","volume":"10","author":"W Ho","year":"2021","unstructured":"Ho W, Gao M, Li F, Li Z, Zhang XQ, Xu X. Next-generation vaccines: nanoparticle-mediated DNA and mRNA delivery. Adv Healthc Mater. 2021;10(8):2001812. https:\/\/doi.org\/10.1002\/adhm.202001812.","journal-title":"Adv Healthc Mater"},{"issue":"7","key":"2036_CR21","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","volume":"25","author":"PR Cullis","year":"2017","unstructured":"Cullis PR, Hope MJ. Lipid nanoparticle systems for enabling gene therapies. Mol Ther. 2017;25(7):1467\u201375. https:\/\/doi.org\/10.1016\/j.ymthe.2017.03.013.","journal-title":"Mol Ther"},{"issue":"7","key":"2036_CR22","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3390\/pharmaceutics13070945","volume":"13","author":"C Delehedde","year":"2021","unstructured":"Delehedde C, Even L, Midoux P, Pichon C, Perche F. Intracellular routing and recognition of lipid-based mRNA nanoparticles. Pharmaceutics. 2021;13(7):945. https:\/\/doi.org\/10.3390\/pharmaceutics13070945.","journal-title":"Pharmaceutics"},{"key":"2036_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9040359","author":"TT Thi","year":"2021","unstructured":"Thi TT, Suys EJA, Lee JS, Nguyen DH, Park KD, Truong NP. Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines. Vaccines. 2021. https:\/\/doi.org\/10.3390\/vaccines9040359.","journal-title":"Vaccines"},{"issue":"10","key":"2036_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241006","volume":"15","author":"RC Ryals","year":"2020","unstructured":"Ryals RC, Patel S, Acosta C, McKinney M, Pennesi ME, Sahay G. The effects of PEGylation on LNP based mRNA delivery to the eye. PLoS One. 2020;15(10):e0241006. https:\/\/doi.org\/10.1371\/journal.pone.0241006.","journal-title":"PLoS One"},{"key":"2036_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add4623","author":"M Herrera-Barrera","year":"2023","unstructured":"Herrera-Barrera M, et al. Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates. Sci Adv. 2023. https:\/\/doi.org\/10.1126\/sciadv.add4623.","journal-title":"Sci Adv"},{"issue":"12","key":"2036_CR26","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.3390\/biom14121558","volume":"14","author":"J Hirose","year":"2024","unstructured":"Hirose J, Aizawa E, Yamamoto S, Xu M, Iwai S, Suzuki K. Lipid nanoparticles enable efficient in vivo DNA knock-in via HITI-mediated genome editing. Biomolecules. 2024;14(12):1558. https:\/\/doi.org\/10.3390\/biom14121558.","journal-title":"Biomolecules"},{"issue":"11","key":"2036_CR27","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1021\/acsptsci.3c00185","volume":"6","author":"D Pozzi","year":"2023","unstructured":"Pozzi D, Caracciolo G. Looking back, moving forward: lipid nanoparticles as a promising frontier in gene delivery. ACS Pharmacol Transl Sci. 2023;6(11):1561\u201373. https:\/\/doi.org\/10.1021\/acsptsci.3c00185.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"7","key":"2036_CR28","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.13.7.7","volume":"13","author":"CZ Chambers","year":"2024","unstructured":"Chambers CZ, et al. Lipid nanoparticle-mediated delivery of mRNA into the mouse and human retina and other ocular tissues. Trans Vis Sci Technol. 2024;13(7):7. https:\/\/doi.org\/10.1167\/tvst.13.7.7.","journal-title":"Trans Vis Sci Technol"},{"issue":"1","key":"2036_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1021\/acs.molpharmaceut.0c00992","volume":"18","author":"X Huang","year":"2021","unstructured":"Huang X, Chau Y. Enhanced delivery of siRNA to retinal ganglion cells by intravitreal lipid nanoparticles of positive charge. Mol Pharm. 2021;18(1):377\u201385. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00992.","journal-title":"Mol Pharm"},{"key":"2036_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jconrel.2019.04.015","volume":"303","author":"S Patel","year":"2019","unstructured":"Patel S, Ryals RC, Weller KK, Pennesi ME, Sahay G. Lipid nanoparticles for delivery of messenger RNA to the back of the eye. J Control Release. 2019;303:91\u2013100. https:\/\/doi.org\/10.1016\/j.jconrel.2019.04.015.","journal-title":"J Control Release"},{"issue":"2","key":"2036_CR31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.nano.2010.07.005","volume":"7","author":"A Kwok","year":"2011","unstructured":"Kwok A, Hart SL. Comparative structural and functional studies of nanoparticle formulations for DNA and siRNA delivery. Nanomedicine Nanotechnol Biol Med. 2011;7(2):210\u20139. https:\/\/doi.org\/10.1016\/j.nano.2010.07.005.","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"issue":"5","key":"2036_CR32","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/pharmaceutics14050998","volume":"14","author":"B Leclercq","year":"2022","unstructured":"Leclercq B, Mejlachowicz D, Behar-Cohen F. Ocular barriers and their influence on gene therapy products delivery. Pharmaceutics. 2022;14(5):998. https:\/\/doi.org\/10.3390\/pharmaceutics14050998.","journal-title":"Pharmaceutics"},{"issue":"1","key":"2036_CR33","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1080\/10717544.2017.1375578","volume":"24","author":"K Peynshaert","year":"2017","unstructured":"Peynshaert K, et al. Toward smart design of retinal drug carriers: a novel bovine retinal explant model to study the barrier role of the vitreoretinal interface. Drug Deliv. 2017;24(1):1384\u201394. https:\/\/doi.org\/10.1080\/10717544.2017.1375578.","journal-title":"Drug Deliv"},{"issue":"1","key":"2036_CR34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jconrel.2013.01.018","volume":"167","author":"Q Xu","year":"2013","unstructured":"Xu Q, et al. Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo. J Control Release. 2013;167(1):76\u201384. https:\/\/doi.org\/10.1016\/j.jconrel.2013.01.018.","journal-title":"J Control Release"},{"issue":"5","key":"2036_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202000057","volume":"4","author":"H Zhang","year":"2020","unstructured":"Zhang H, et al. Fluorescence-based quantification of messenger RNA and plasmid DNA decay kinetics in extracellular biological fluids and cell extracts. Adv Biosyst. 2020;4(5):2000057. https:\/\/doi.org\/10.1002\/adbi.202000057.","journal-title":"Adv Biosyst"},{"key":"2036_CR36","doi-asserted-by":"publisher","DOI":"10.1101\/2023.04.20.537413","author":"KN Haggerty","year":"2023","unstructured":"Haggerty KN, Eshelman SC, Sexton LA, Frimpong E, Rogers LM, Agosto MA, et al. Mapping rhodopsin trafficking in rod photoreceptors with quantitative super-resolution microscopy. bioRxiv. 2023. https:\/\/doi.org\/10.1101\/2023.04.20.537413.","journal-title":"bioRxiv"},{"issue":"3","key":"2036_CR37","first-page":"718","volume":"36","author":"FC Delori","year":"1995","unstructured":"Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Weiter JJ. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci. 1995;36(3):718\u201329.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"2036_CR38","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1364\/BOE.2.001494","volume":"2","author":"RW Lu","year":"2011","unstructured":"Lu RW, Li YC, Ye T, Strang C, Keyser K, Curcio CA, et al. Two-photon excited autofluorescence imaging of freshly isolated frog retinas. Biomed Opt Express. 2011;2(11):1494\u2013503. https:\/\/doi.org\/10.1364\/BOE.2.001494.","journal-title":"Biomed Opt Express"},{"key":"2036_CR39","doi-asserted-by":"publisher","unstructured":"Shayler DWH et al. Single cell transcriptomics reveals early photoreceptor states, cell-specific transcript isoforms, and cancer-predisposing features. bioRxiv. 2023;2(28):530247\u20132024.\u00a0https:\/\/doi.org\/10.1101\/2023.02.28.530247.","DOI":"10.1101\/2023.02.28.530247"},{"issue":"51","key":"2036_CR40","doi-asserted-by":"publisher","first-page":"56666","DOI":"10.1021\/acsami.2c20019","volume":"14","author":"E Quagliarini","year":"2022","unstructured":"Quagliarini E, et al. Mechanistic insights into the superior DNA delivery efficiency of multicomponent lipid nanoparticles: an in vitro and in vivo study. ACS Appl Mater Interfaces. 2022;14(51):56666\u201377. https:\/\/doi.org\/10.1021\/acsami.2c20019.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2036_CR41","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jconrel.2024.12.002","volume":"378","author":"M Hosseini-Kharat","year":"2025","unstructured":"Hosseini-Kharat M, Bremmell KE, Grubor-Bauk B, Prestidge CA. Enhancing non-viral DNA delivery systems: recent advances in improving efficiency and target specificity. J Control Release. 2025;378:170\u201394. https:\/\/doi.org\/10.1016\/j.jconrel.2024.12.002.","journal-title":"J Control Release"},{"issue":"4","key":"2036_CR42","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/J.NANO.2016.12.014","volume":"13","author":"JA Kulkarni","year":"2017","unstructured":"Kulkarni JA, et al. Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA. Nanomed Nanotechnol Biol Med. 2017;13(4):1377\u201387. https:\/\/doi.org\/10.1016\/J.NANO.2016.12.014.","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"11","key":"2036_CR43","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1039\/d2bm00168c","volume":"10","author":"A Algarni","year":"2022","unstructured":"Algarni A, Pilkington EH, Suys EJA, Al-Wassiti H, Pouton CW, Truong NP. In vivo delivery of plasmid DNA by lipid nanoparticles: the influence of ionizable cationic lipids on organ-selective gene expression. Biomater Sci. 2022;10(11):2940\u201352. https:\/\/doi.org\/10.1039\/d2bm00168c.","journal-title":"Biomater Sci"},{"key":"2036_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2023.102697","volume":"53","author":"L Digiacomo","year":"2023","unstructured":"Digiacomo L, et al. Investigating the mechanism of action of DNA-loaded PEGylated lipid nanoparticles. Nanomed Nanotechnol Biol Med. 2023;53:102697. https:\/\/doi.org\/10.1016\/j.nano.2023.102697.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"2036_CR45","doi-asserted-by":"crossref","unstructured":"Cui L, Renzi S, Quagliarini E, Digiacomo L, Amenitsch H, Masuelli L, Bei R, Ferri G, Cardarelli F, Wang J, Amici A. Efficient delivery of DNA using lipid nanoparticles. Pharmaceutics. 2022;15(14)8:1698. Available: https:\/\/www.mdpi.com\/1999-4923\/14\/8\/1698.","DOI":"10.3390\/pharmaceutics14081698"},{"key":"2036_CR46","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.2147\/IJN.S457302","volume":"19","author":"I Ottonelli","year":"2024","unstructured":"Ottonelli I, et al. Strategies for improved pDNA loading and protection using cationic and neutral LNPs with industrial scalability potential using microfluidic technology. Int J Nanomedicine. 2024;19:4235\u201351. https:\/\/doi.org\/10.2147\/IJN.S457302.","journal-title":"Int J Nanomedicine"},{"key":"2036_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53569-8","author":"S Renzi","year":"2024","unstructured":"Renzi S, et al. Structuring lipid nanoparticles, DNA, and protein corona into stealth bionanoarchitectures for in vivo gene delivery. Nat Commun. 2024. https:\/\/doi.org\/10.1038\/s41467-024-53569-8.","journal-title":"Nat Commun"},{"key":"2036_CR48","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.2147\/IJN.S366962","volume":"17","author":"S Scalzo","year":"2022","unstructured":"Scalzo S, et al. Ionizable lipid nanoparticle-mediated delivery of plasmid DNA in cardiomyocytes. Int J Nanomedicine. 2022;17:2865\u201381. https:\/\/doi.org\/10.2147\/IJN.S366962.","journal-title":"Int J Nanomedicine"},{"key":"2036_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jconrel.2024.03.018","volume":"369","author":"Y Qin","year":"2024","unstructured":"Qin Y, et al. Plasmid DNA ionisable lipid nanoparticles as non-inert carriers and potent immune activators for cancer immunotherapy. J Control Release. 2024;369:251\u201365. https:\/\/doi.org\/10.1016\/j.jconrel.2024.03.018.","journal-title":"J Control Release"},{"issue":"10","key":"2036_CR50","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.3390\/vaccines11101580","volume":"11","author":"W Zhang","year":"2023","unstructured":"Zhang W, et al. The expression kinetics and immunogenicity of lipid nanoparticles delivering plasmid DNA and mRNA in mice. Vaccines. 2023;11(10):1580. https:\/\/doi.org\/10.3390\/vaccines11101580.","journal-title":"Vaccines"},{"key":"2036_CR51","doi-asserted-by":"publisher","unstructured":"Patel MN, et al (2025)Safer non-viral DNA delivery using lipid nanoparticles loaded with endogenous anti-inflammatory lipids. Nature Biotechnol 1-1. https:\/\/doi.org\/10.1038\/s41587-025-02556-5.","DOI":"10.1038\/s41587-025-02556-5"},{"key":"2036_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31993-y","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, et al. Multi-step screening of DNA\/lipid nanoparticles and co-delivery with siRNA to enhance and prolong gene expression. Nat Commun. 2022. https:\/\/doi.org\/10.1038\/s41467-022-31993-y.","journal-title":"Nat Commun"},{"issue":"1","key":"2036_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02211-8","volume":"24","author":"D Chai","year":"2025","unstructured":"Chai D, et al. Lipid nanoparticles deliver DNA-encoded biologics and induce potent protective immunity. Mol Cancer. 2025;24(1):12. https:\/\/doi.org\/10.1186\/s12943-024-02211-8.","journal-title":"Mol Cancer"},{"issue":"1","key":"2036_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2023.101169","volume":"32","author":"H-C Liao","year":"2024","unstructured":"Liao H-C, et al. Lipid nanoparticle-encapsulated DNA vaccine robustly induce superior immune responses to the mRNA vaccine in Syrian hamsters. Mol Ther Methods Clin Dev. 2024;32(1):101169. https:\/\/doi.org\/10.1016\/j.omtm.2023.101169.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"4","key":"2036_CR55","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00249-023-01663-y","volume":"52","author":"A Bepperling","year":"2023","unstructured":"Bepperling A, Richter G. Determination of mRNA copy number in degradable lipid nanoparticles via density contrast analytical ultracentrifugation. Eur Biophys J. 2023;52(4):393\u2013400. https:\/\/doi.org\/10.1007\/s00249-023-01663-y.","journal-title":"Eur Biophys J"},{"issue":"1","key":"2036_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-02441-2","volume":"4","author":"MJ Carrasco","year":"2021","unstructured":"Carrasco MJ, et al. Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration. Commun Biol. 2021;4(1):956. https:\/\/doi.org\/10.1038\/s42003-021-02441-2.","journal-title":"Commun Biol"},{"key":"2036_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2024.102745","volume":"58","author":"B Liau","year":"2024","unstructured":"Liau B, et al. Quantitative analysis of mRNA-lipid nanoparticle stability in human plasma and serum by size-exclusion chromatography coupled with dual-angle light scattering. Nanomedicine Nanotechnol Biol Med. 2024;58:102745. https:\/\/doi.org\/10.1016\/j.nano.2024.102745.","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"issue":"4","key":"2036_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102035","volume":"6","author":"NJ Tursi","year":"2025","unstructured":"Tursi NJ, et al. Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunity. Cell Rep Med. 2025;6(4):102035. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102035.","journal-title":"Cell Rep Med"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-02036-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-02036-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-02036-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:32:26Z","timestamp":1783513946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-02036-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2036"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-02036-y","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiments in this work comply with the current laws of the country in which they were performed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical standards"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"N\/A","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent and consent to participate"}},{"value":"No animal or human studies were carried out by the authors for this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}},{"value":"N\/A","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}